0000000000275966

AUTHOR

Yi Luo

showing 4 related works from this author

In situ crosslinkable hyaluronan hydrogels for tissue engineering

2003

We describe the development of an injectable, cell-containing hydrogel that supports cell proliferation and growth to permit in vivo engineering of new tissues. Two thiolated hyaluronan (HA) derivatives were coupled to four alpha,beta-unsaturated ester and amide derivatives of poly(ethylene glycol) (PEG) 3400. The relative chemical reactivity with cysteine decreased in the order PEG-diacrylate (PEGDA)>>PEG-dimethacrylate>PEG-diacrylamide>PEG-dimethacrylamide. The 3-thiopropanoyl hydrazide derivative (HA-DTPH) was more reactive than the 4-thiobutanoyl hydrazide, HA-DTBH. The crosslinking of HA-DTPH with PEGDA in a molar ratio of 2:1 occurred in approximately 9 min, suitable for an in situ cr…

MaleMaterials sciencePolyethylene glycolCell SurvivalBiophysicsMice NudeBioengineeringBiocompatible Materialsmacromolecular substancesPolyethylene glycolBiomaterialschemistry.chemical_compoundMiceTissue engineeringIn vivoPEG ratioHyaluronic acidMaterials TestingmedicineAnimalsHumansHyaluronic AcidCell encapsulationFibroblastCells CulturedTissue EngineeringForeign-Body Reactiontechnology industry and agricultureHydrogelsCell encapsulationFibroblastsmedicine.anatomical_structureCross-Linking ReagentsBiochemistrychemistryGlycosaminoglycanDiacrylateCell-compatible crosslinkingMechanics of MaterialsSelf-healing hydrogelsCeramics and CompositesBiophysicsIn vivo biocompatibilityCell Division
researchProduct

Collagen biology and non‐invasive biomarkers of liver fibrosis

2020

There is an unmet need for high-quality liquid biomarkers that can safely and reproducibly predict the stage of fibrosis and the outcomes of chronic liver disease (CLD). The requirement for such markers has intensified because of the high global prevalence of diseases such as non-alcoholic fatty liver disease (NAFLD). In particular, there is a need for diagnostic and prognostic tools, as well as predictive biomarkers that reflect the efficacy of interventions, as described by the BEST criteria (Biomarkers, EndpointS, and other Tools Resource). This review covers the various liver collagens, their functional role in tissue homeostasis and delineates the common nomenclature for biomarkers bas…

Liver CirrhosisLiver injuryCirrhosisHepatologyFatty liverDiseaseBiologyBioinformaticsmedicine.diseaseChronic liver disease03 medical and health sciences0302 clinical medicineLiverNon-alcoholic Fatty Liver DiseaseFibrosis030220 oncology & carcinogenesismedicineHumansBiomarker (medicine)030211 gastroenterology & hepatologyCollagenBiologyBiomarkersTissue homeostasisLiver International
researchProduct

Assessment of liver fibrosis progression and regression by a serological collagen turnover profile

2018

There is a need for noninvasive biomarkers that can identify patients with progressive liver fibrosis and monitor response to antifibrotic therapy. An equally important need is identification of patients with spontaneous fibrosis regression, since they may not need treatment nor be included in clinical studies with fibrosis as end point. Circulating biomarkers, originating from defined fragments of the scar tissue itself, may serve as valuable tools for this aspect of precision medicine. We investigated a panel of serological collagen formation and degradation markers to identify patients likely to regress or progress in absence of a therapeutic intervention. Plasma samples from patients wi…

0301 basic medicineAdultLiver CirrhosisMalePathologymedicine.medical_specialtyPhysiologyLiver fibrosisBiopsySerology03 medical and health sciences0302 clinical medicinePhysiology (medical)medicineHumansBasement membraneHepatologybusiness.industryGastroenterologyMiddle AgedFibrosis3. Good healthProcollagen peptidase030104 developmental biologymedicine.anatomical_structurePhenotypeDisease ProgressionBiomarker (medicine)030211 gastroenterology & hepatologyFemaleCollagenbusinessBiomarkersAmerican Journal of Physiology-Gastrointestinal and Liver Physiology
researchProduct

Attachement and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel

2004

Hyaluronan (HA) hydrogels resist attachment and spreading of fibroblasts and most other mammalian cell types. A thiol-modified HA (3,3'-dithiobis(propanoic dihydrazide) [HA-DTPH]) was modified with peptides containing the Arg-Gly-Asp (RGD) sequence and then crosslinked with polyethylene glycol (PEG) diacrylate (PEGDA) to create a biomaterial that supported cell attachment, spreading, and proliferation. The hydrogels were evaluated in vitro and in vivo in three assay systems. First, the behavior of human and murine fibroblasts on the surface of the hydrogels was evaluated. The concentration and structure of the RGD peptides and the length of the PEG spacer influenced cell attachment and spre…

Materials scienceTime FactorsBiomedical EngineeringCell Culture TechniquesRGD Hyaluronic acidPeptideBiocompatible Materialsmacromolecular substancesBiomaterialschemistry.chemical_compoundMiceTissue engineeringIn vivoCell MovementHyaluronic acidPEG ratioCell AdhesionAnimalsHyaluronic Acidchemistry.chemical_classificationbiologytechnology industry and agricultureHydrogelsFibroblastsMolecular biologyFibronectinchemistryCell cultureSelf-healing hydrogelsbiology.proteinBiophysicsNIH 3T3 CellsOligopeptides
researchProduct